All Channels

Add to Favorites Subscribe Share
fbshare-

Showing results

110 of 223141

Current treatment for fungal meningitis is fueling drug resistance

University of Liverpool

A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, new University of Liverpool research warns.

Channels: AIDS and HIV, All Journal News, Immunology, Infectious Diseases, Public Health, Drug Resistance,

Released:
6-Dec-2019 3:05 PM EST
Open in New Tab
Comment
Newswise: 218927_web.jpg

Gulf Coast corals face catastrophe

Rice University

If coral reefs are the canary to the ocean's coal mine, it's getting awfully bleak in the Gulf of Mexico.

Channels: All Journal News, Climate Science, Environmental Science, Marine Science,

Released:
6-Dec-2019 3:05 PM EST
Open in New Tab
Comment
Research Results
WoltersKluwer_CMYK-ol.jpg

Patient Factors Explain Most of the Variation in Function After Lower Spinal Fusion

Wolters Kluwer Health: Lippincott Williams and Wilkins

Patient-reported functional outcomes vary considerably after lower (lumbar) spinal fusion surgery. But the variability mainly reflects patient characteristics, rather than differences in care provided by surgeons or hospitals, suggests a study in Spine. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Channels: All Journal News, Bone Health, Neuro,

Released:
6-Dec-2019 2:25 PM EST
Open in New Tab
Comment
Research Results
Newswise: Student thoughts: Finals are the pits

Student thoughts: Finals are the pits

Wichita State University

Wichita State University senior Madison Harris expresses an opinion likely shared by thousands of college students across America at this time of year.

Channels: Behavioral Science, Education,

Released:
6-Dec-2019 2:05 PM EST
Open in New Tab
Comment
Expert Pitch

Education

Rutgers-led Team Launches Science and Medicine Research Initiative to Transform Health Care in New Jersey

Rutgers University-New Brunswick

At an event Thursday at Rutgers, thought leaders from academia, health care, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state, as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

Channels: Clinical Trials, Government/Law, Healthcare, Pharmaceuticals, U.S. Politics, National Institutes of Health (NIH),

Released:
6-Dec-2019 2:05 PM EST
Open in New Tab
Comment
Feature

Law and Public Policy

Newswise: New Ultra-Miniaturized Scope Less Invasive, Produces Higher Quality Images
  • Embargo expired:
    6-Dec-2019 2:00 PM EST

New Ultra-Miniaturized Scope Less Invasive, Produces Higher Quality Images

Johns Hopkins University

Johns Hopkins engineers have created a new lens-free ultra-miniaturized endoscope, the size of a few human hairs in width, that is less bulky and can produce higher quality images.

Channels: Engineering, Technology, All Journal News, Grant Funded News,

Released:
6-Dec-2019 8:50 AM EST
Open in New Tab
Comment
Announcement
Newswise: Little Size Holds Big Impact: Johns Hopkins Scientists Develop Nanocontainer to Ship Titan-Size Gene Therapies And Drugs Into Cells
  • Embargo expired:
    6-Dec-2019 2:00 PM EST

Little Size Holds Big Impact: Johns Hopkins Scientists Develop Nanocontainer to Ship Titan-Size Gene Therapies And Drugs Into Cells

Johns Hopkins Medicine

Scientists at Johns Hopkins Medicine report they have created a tiny, nanosize container that can slip inside cells and deliver protein-based medicines and gene therapies of any size — even hefty ones attached to the gene-editing tool called CRISPR. If their creation – constructed of a biodegradable polymer — passes more laboratory testing, it could offer a way to efficiently ferry larger medical compounds into specifically selected target cells.

Channels: All Journal News, Nanotechnology, Particle Physics, Physics, Grant Funded News,

Released:
4-Dec-2019 11:00 AM EST
Open in New Tab
Comment
Research Results
Newswise: Technique shows how individual cancer cells react to drugs

Technique shows how individual cancer cells react to drugs

University of Washington School of Medicine

A new technique reported in Science offers more detail, at the single cell level, on how large, pooled samples of various cells react to drugs or other agents. The data might reveal mode of action or the effect of genetic differences in varying responses.

Channels: All Journal News, Cancer, Cell Biology, Genetics, Pharmaceuticals,

Released:
6-Dec-2019 1:05 PM EST
Open in New Tab
Comment
Expert Pitch

Showing results

110 of 223141

Chat now!
5.53598